Supplemental Figures
. Secondary structure prediction of human SCaMC-1 NTD Secondary structure prediction of human SCaMC-1 NTD was performed using the PSIPRED secondary structure prediction method (Jones, 1999) . The predicted helices are shown as pink tubes and numbered as in Figure 1B . Otherwise, the lines represent predicted coil regions. Residue-specific confidences of prediction are represented by blue bars. Although residues 2-8 were predicted to form helix, we did not observe either crystallographic densities or NMR resonances for these residues. Sequences encompassing the H9 helix from 21 SCaMC paralogs and homologs (from the UniProtKB database) are aligned using program ClustalW2 (Goujon et al., 2010) . SCaMC is named as Sal1p in
Saccharomyces cerevisiae. Residues with more than 70% conservation are colored in red. The five hydrophobic residues involved in binding to the EF hands are highlighted in yellow. The figure was generated using program ESPript (Gouet et al., 1999) . 
Supplemental Experimental Procedures

Sample preparation
For preparing the NTD samples, a gene encoding residues 1-193 of SCaMC-1 and a C-terminal 6His-tag was synthesized by GenScript and subsequently cloned into pET21a expression vector. The NTD was expressed in BL21 (DE3) For preparing the TMD samples, a gene encoding residues 185-477 and a C-terminal 6His-tag was synthesized by GenScript and cloned into pET21a expression vector. TMD was also expressed in BL21
(DE3) cells and purified using a protocol similar to that previously reported (Berardi et al., 2011) .
Briefly, after cell lysis, TMD was extracted from cell membrane by adding 1% DPC into the cell lysate.
The solublized TMD was loaded on a Ni-NTA resin and eluted with 0.1% DPC and 300 mM imidazole.
The protein was further purified on a Superdex S200 size exclusion column in 0.1% DPC, 20 mM HEPES (pH 7.4), and 150 mM NaCl.
Crystallization, data collection, and structure determination
The Ca 2+ -bound NTD was crystallized by hanging-drop vapor diffusion by mixing 1 µl of 0.5 mM protein sample with the reservoir solution consisting of 50 mM Tris (pH 7.8), 2 M lithium sulfate, and 4% (w/v) PEG 400 at 20 °C. Complete multiple wavelength anomalous diffraction (MAD) datasets were collected at Advanced Photon Source at Argonne National Laboratory with one selenomethioninelabeled crystal. The crystal belongs to the space group P6 2 22 and diffracted to a maximum resolution of 2.9 Å. A second crystal form was obtained using 100 mM CHES (pH 9.1) and 20% PEG3350 as crystallization solution. Complete X-ray diffraction data at 2.1 Å was recorded at 100 K at l = 1.5418 Å on an inhouse MAR345 detector (MAR Research) mounted on a Bruker AXS rotating anode generator.
This crystal belongs to the space group P3 1 21. Data were processed using the HKL2000 suite of programs (Otwinowski and Minor, 1997) . Attempts to crystallize NTD in the absence of Ca 2+ were unsuccessful.
The NTD structure was solved by MAD with the P6 2 22 crystal dataset using the program Phenix.AutoSol (Adams et al., 2010) . After density modification, 134 out of 193 residues were built using Phenix.AutoBuild (Adams et al., 2010) . This model was subsequently used as a search model for molecular replacement of the P3 1 21 crystal using the program Phaser (McCoy et al., 2007) . Further improvements of the model from the P3 1 21 crystal were made using the program COOT (Emsley et al., 2010) , followed by iterative cycles of positional and B-factor refinement performed using the program Phenix.Refine (Adams et al., 2010) . The overall quality of the structure was evaluated using MOLPROBITY . Data collection and refinement statistics are summarized in Table 1 .
NMR spectroscopy
NMR experiments were performed at 30 °C on 600 MHz Bruker spectrometer equipped with cryogenic TXI probe, except for relaxation data, which were recorded at 750 MHz. Data processing and spectra analyses were performed using programs NMRPipe (Delaglio et al., 1995) , CARA (Keller, 2004) and CcpNmr (Vranken et al., 2005 (Losonczi et al., 1999) , using the program PALES (Zweckstetter and Bax, 2000) . The goodness of fit was assessed by both Pearson correlation coefficient (R) and the quality factor (Q) (Cornilescu et al., 1998) .
Dynamics measurements for apo and Ca 2+ -bound NTD were performed at 30 °C and on 750 MHz Bruker spectrometer. 15 N R 1 , R 2 , and 15 N( 1 H) NOE were measured using the standard pulse schemes described previously (Kay et al., 1989) . The heteronuclear 15 N( 1 H) NOE was measured by recording HSQC spectrum with and without 3 s duration of proton saturation in an interleaved manner. 
SPR measurements of NTD-TMD interaction.
SPR experiments were performed with the Biacore 3000 instrument (GE healthcare) at 25 °C using a protocol similar to that described previously (Hodnik and Anderluh, 2010; Stahelin, 2013) . The experimental design involves 1) immobilizing the TMD proteoliposomes on the L1 sensor chip via interaction between the tail groups of lipids and the alkane groups present on the carboxymethyldextran-coated chip surface and 2) flowing NTD through the sensor chip in the absence and presence of Ca 2+ . After the L1 sensor chip (GE healthcare) was washed with SPR running buffer (20 mM HEPES (pH 7.0), 150 mM NaCl, and 5 mM EDTA), TMD proteoliposomes or empty liposomes were injected at 10 µl/min for 15 minutes into active flow cell or control flow cell, respectively. The immobilized proteoliposomes were stabilized with injection of 20 µl of 2 M NaCl, followed by 10 µl of 0.1 mg/ml bovine serum albumin (BSA) (for saturating the nonspecific binding sites). To measure binding, apo NTD in the SPR buffer with 0.1 mg/ml BSA was injected at increasing concentrations (1, 3, 10, 30, 100, 300 and 600 mM) at 2 µl/min for 3 minutes. The response in signal (RU) at each of the above protein concentration was recorded. Likewise, Ca 2+ -bound NTD in HEPES (pH7.0), 150 mM NaCl, 0.1 mg/ml BSA and 5 mM CaCl 2 was injected at the same rate at concentrations of 9, 18.5, 37.5, 75, 150, 300 and 600 mM. The experiments were performed in triplicate. SPR data processing and analysis were performed using the program BIAevaluation (GE healthcare). Sensorgrams were corrected for changes in the refractive index of the buffer and nonspecific binding by subtracting the response of the control channel with immobilized empty liposomes.
Equilibrium signal (R eq ) at a given NTD concentration (C) were plotted and fit to the equation R eq = R max /(1 + K D /C) to determine the equilibrium binding constant (K D ). R max is the binding signal at saturation.
